David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
1426
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $5.68M | 0.01% |
454,853
+204,451
| +82% | +$2.73M |
|
|
VSI
1427
DELISTED
Vitamin Shoppe Inc.
VSI
| $5.67M | 0.01% |
806,120
+276,654
| +52% | +$1.63M |
|
|
MLNX
1428
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $5.67M | 0.01% |
47,900
+19,900
| +71% | +$2M |
|
1429
PUT
American Express
AXP
$227B
| $5.66M | 0.01% |
51,800
+7,400
| +17% | +$778K |
|
|
B
1430
DELISTED
Barnes Group Inc.
B
| $5.65M | 0.01% |
109,863
+44,113
| +67% | +$2.51M |
|
1431
Jabil
JBL
$32.6B
| $5.64M | 0.01% |
212,225
-336,318
| -61% | -$8.98M |
|
1432
Markel Group
MKL
$22.5B
| $5.63M | 0.01% |
5,648
+1,543
| +38% | +$1.57M |
|
1433
PUT
Illumina
ILMN
$34B
| $5.62M | 0.01% |
18,607
| – | – |
|
1434
Maximus
MMS
$3.09B
| $5.62M | 0.01% |
79,212
-40,736
| -34% | -$2.86M |
|
1435
Vishay Precision Group
VPG
$853M
| $5.62M | 0.01% |
164,184
-18,315
| -10% | -$612K |
|
1436
AZZ Inc
AZZ
$4.23B
| $5.61M | 0.01% |
137,127
+4,686
| +4% | +$207K |
|
1437
CALL
Cboe Global Markets
CBOE
$32.6B
| $5.61M | 0.01% |
58,800
-49,100
| -46% | -$4.66M |
|
1438
Enova International
ENVA
$5.89B
| $5.6M | 0.01% |
245,383
-56,281
| -19% | -$1.33M |
|
|
GRUB
1439
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $5.6M | 0.01% |
40,300
-18,500
| -31% | -$2.87M |
|
|
PRMW
1440
DELISTED
Primo Water Corporation
PRMW
| $5.58M | 0.01% |
382,220
-266,661
| -41% | -$4.01M |
|
|
UCB
1441
United Community Banks
UCB
$4.25B
| $5.58M | 0.01% |
223,779
+16,280
| +8% | +$423K |
|
1442
CALL
PG&E
PCG
$40.1B
| $5.57M | 0.01% |
313,000
+183,700
| +142% | +$2.97M |
|
|
MIK
1443
DELISTED
Michaels Stores, Inc
MIK
| $5.56M | 0.01% |
487,253
-373,599
| -43% | -$5.12M |
|
1444
PUT
MetLife
MET
$61.3B
| $5.55M | 0.01% |
130,500
-124,800
| -49% | -$5.52M |
|
1445
CALL
Shake Shack
SHAK
$2.95B
| $5.52M | 0.01% |
93,300
-400
| -0.4% | -$20.5K |
|
1446
Golub Capital BDC
GBDC
$3.4B
| $5.51M | 0.01% |
314,832
+121,909
| +63% | +$2.15M |
|
1447
Federal Signal
FSS
$7.42B
| $5.51M | 0.01% |
212,124
-11,509
| -5% | -$263K |
|
1448
PUT
Seagate
STX
$192B
| $5.51M | 0.01% |
115,000
-65,000
| -36% | -$2.88M |
|
1449
West Pharmaceutical
WST
$24.6B
| $5.49M | 0.01% |
+49,778
| New | +$5.18M |
|
|
BECN
1450
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $5.48M | 0.01% |
170,412
+40,086
| +31% | +$1.4M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.